(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

The best ways to get rid of phlegm, from using nasal sprays to taking the right OTC medications. Plus, they explain what ...

A retrial into the death of football legend Diego Maradona is set to begin on Tuesday. Maradona passed away on November 25, ...

The trial will, once again, seek to determine if Maradona’s medical team was responsible for his death in November 2020.

NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...

Background: Chronic obstructive pulmonary disease (COPD), marked by dyspnea, cough, and sputum production, significantly impairs patients’ quality of life and functionality. Effective management ...

Norway's Crown Princess wore a nasal cannula to royal outing for the first time ...

By early detection of fluid in the lungs, a device allows early therapy adjustments to reduce all-cause mortality in patients ...

The Frontenac, Lennox and Addington Ontario Health Team (FLA OHT) is hosting a 'Living Well Together' event for patients, ...

AstraZeneca jumps 4% after COPD drug wins Phase 3 trials. Tozorakimab success seen as rare win in tough COPD drug race. Strong trial data boosts AstraZeneca’s long-term revenue outlook. Shares of ...

Introduction Transitions of care (TOC) between hospital, ambulatory and home settings for high-risk adults with chronic diseases are complex, costly and often result in poor health outcomes.

AURA Phase 2 clinical trial designed to evaluate the safety and efficacy of AP02 compared to placebo in patients with idiopathic pulmonary fibrosis (IPF) BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- ...